Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients (Q38796138)

6 September 2017

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients (English)

1 reference

6 September 2017

1 reference

4

J-C Soria

0 references

Marie-Christine Mathieu

5

object named as

M-C Mathieu

0 references

author name string

N Ady

1

1 reference

6 September 2017

L Morat

2

1 reference

6 September 2017

K Fizazi

3

1 reference

6 September 2017

J-C Soria

4

1 reference

6 September 2017

M-C Mathieu

5

1 reference

6 September 2017

D Prapotnich

6

1 reference

6 September 2017

L Sabatier

7

1 reference

6 September 2017

L Chauveinc

8

1 reference

6 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

British Journal of Cancer

6 September 2017

1 reference

6 September 2017

90

1 reference

6 September 2017

2

1 reference

6 September 2017

443-448

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601532

6 September 2017

0 references

cites work

HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

New concepts in the pathology of prostatic epithelial carcinogenesis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Blood-borne RT-PCR assay for prostasin- specific transcripts to identify circulating prostate cells in cancer patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Role of HER2 gene overexpression in breast carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

The biology of erbB-2/neu/HER-2 and its role in cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Transfected neu oncogene induces human prostate cancer metastasis

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409539

Overexpression of her-2/neu in human prostate cancer and benign hyperplasia

31 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601532

Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence

21 January 2018

1 reference

12 December 2020

Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer

1 reference

12 December 2020

The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor

1 reference

12 December 2020

Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer

1 reference

12 December 2020

Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays

1 reference

12 December 2020

Detection of circulating tumor cells in men with localized prostate cancer

1 reference

12 December 2020

Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications

1 reference

12 December 2020

Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients

1 reference

12 December 2020

c-erbB-2 oncoprotein: a potential biomarker of advanced prostate cancer

1 reference

12 December 2020

Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages

1 reference

12 December 2020

Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival

1 reference

12 December 2020

Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients

1 reference

12 December 2020

Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models

1 reference

12 December 2020

HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer

1 reference

12 December 2020

HER-2 profiling and targeting in prostate carcinoma

1 reference

12 December 2020

Clinical states in prostate cancer: toward a dynamic model of disease progression

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601532

1 reference

Dimensions Publication ID

6 September 2017

1009227231

0 references

Fatcat ID

release_qu4tnczbljhjpky5ualejr3zoq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qu4tnczbljhjpky5ualejr3zoq

24 November 2022

mapped directly with Wikidata item

1 reference

6 September 2017

1 reference